Menu Back toSession 7: Artificial Intelligence (AI) and Machine Learning (ML) Use in Clinical Trials: How Do We Use Artificial Intelligence (AI) and Machine Learning (ML) in Clinical Trials?

Digital Technology in Clinical Trials Conference

Digital Technology in Clinical Trials Conference is now fully virtual. Join us from the comfort of your own space!


Session 7: Artificial Intelligence (AI) and Machine Learning (ML) Use in Clinical Trials: How Do We Use Artificial Intelligence (AI) and Machine Learning (ML) in Clinical Trials?

Session Chair(s)

Steven  Murray, PhD

Steven Murray, PhD

  • Group Vice President and Principal Engineer, Electrical and Data Sciences
  • Exponent, United States
An exploration of the use of advanced analytics for clinical trials. Can these techniques add insight? Will the regulators buy it? We will explore what technical things are possible, and how they can be measured.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Understand the regulatory concerns or requirements for using AI and ML in clinical trials
  • Grasp the benefits and limitations of using this technology
  • Start a thought process about how they might incorporate these technologies into future trials if possible

Speaker(s)

Tai  Xie, PhD

Dynamic Data Monitoring for Ongoing Clinical Trials

Tai Xie, PhD

  • Founder and CEO
  • CIMS Global, United States
Seleen  Ong, MRCP, MSc, FFPM

Speaker

Seleen Ong, MRCP, MSc, FFPM

  • Executive Director Clinical Group Lead
  • Pfizer, Inc., United Kingdom
Tala  Fakhouri, PhD, MPH

Speaker

Tala Fakhouri, PhD, MPH

  • Associate Director for Policy Analysis, Office of Medical Policy, CDER
  • FDA, United States